Novartis A Buy At Chardan
September 20, 2016 at 10:15 AM EDT
Chardan Capital’s Gbola Amusa believes Novartis AG (ADR) (NYSE: NVS) has the “potential for excess shareholder returns over ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.